Search Results 341-350 of 17217 for Selective mutism
Venetoclax is a selective, orally bioavailable small-molecule BCL-2 inhibitor; bortezomib can indirectly inhibit MCL-1. In preclinical studies, venetoclax ...
The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
The study will also determine if VEP's remain reliably stable in amplitude and latency during non-cranial surgery using total intravenous anesthesia (TIVA), and ...
The purpose of this study is to find out if some patients with mood symptoms have antibodies (part of the immune system) that affect the brain, and could ...
The purpose of this study is to determine if open surgical resection is superior to thoracoscopic resection for thoracic event-free survival (tEFS) in ...
About this study. The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...
The goal of this research is to investigate the hypothesis that this presentation represents a spatially limited form of CNS inflammatory demyelinating disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.